English
简体中文
Total: £ 56.28
Published Date: 2025-12-23 | Pages: 96 | Tables: 95 | Pharma & Healthcare
The global market for Pharmaceutical Carbohydrate Excipients was valued at US$ 1713 million in the year 2024 and is projected to reach a revised size of US$ 2495 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Pharmaceutical carbohydrate excipients refer to carbohydrate substances used as excipients in pharmaceutical preparations. They usually originate from natural plant or animal resources, such as starch, glucose, sucrose, and lactose, and have multiple functions and uses. These excipients primarily serve as stabilizers in pharmaceutical preparations, maintaining the physical and chemical stability of drugs and preventing degradation or deterioration during storage and transportation. At the same time, they can also serve as energy sources, providing necessary energy support for drugs and thereby enhancing their efficacy. Furthermore, pharmaceutical carbohydrate excipients can improve the taste and flavor of drugs, making them more acceptable and easier for patients to take. During the pharmaceutical manufacturing process, the types and quantities of pharmaceutical carbohydrate excipients require strict screening and control to ensure the safety and effectiveness of the drugs.
North American market for Pharmaceutical Carbohydrate Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Carbohydrate Excipients is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pharmaceutical Carbohydrate Excipients include Pfanstiehl, ADM, Protheragen-ING, DFE Pharma, Meggle-Pharma, Roquette, Kerry Group, Colorcon, Signet, IMCD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Carbohydrate Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Carbohydrate Excipients.
The Pharmaceutical Carbohydrate Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Carbohydrate Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Carbohydrate Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfanstiehl
ADM
Protheragen-ING
DFE Pharma
Meggle-Pharma
Roquette
Kerry Group
Colorcon
Signet
IMCD
SPI Pharma
Huakang Pharma
Hanjiang Pharma
Segment by Type
Sucrose
Glucose
Starch
Others
Segment by Application
Oral Preparations
Injectable Preparations
Topical Preparations
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Carbohydrate Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Carbohydrate Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pharmaceutical Carbohydrate Excipients Market Overview
1.1 Product Definition
1.2 Pharmaceutical Carbohydrate Excipients by Type
1.2.1 Global Pharmaceutical Carbohydrate Excipients Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sucrose
1.2.3 Glucose
1.2.4 Starch
1.2.5 Others
1.3 Pharmaceutical Carbohydrate Excipients by Application
1.3.1 Global Pharmaceutical Carbohydrate Excipients Market Value by Application (2024 VS 2031)
1.3.2 Oral Preparations
1.3.3 Injectable Preparations
1.3.4 Topical Preparations
1.3.5 Others
1.4 Global Pharmaceutical Carbohydrate Excipients Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Carbohydrate Excipients Revenue 2020-2031
1.4.2 Global Pharmaceutical Carbohydrate Excipients Sales 2020-2031
1.4.3 Global Pharmaceutical Carbohydrate Excipients Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Carbohydrate Excipients Market Competition by Manufacturers
2.1 Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Carbohydrate Excipients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Carbohydrate Excipients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Date of Enter into This Industry
2.8 Global Pharmaceutical Carbohydrate Excipients Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Carbohydrate Excipients Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Carbohydrate Excipients Players Market Share by Revenue
2.8.3 Global Pharmaceutical Carbohydrate Excipients Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Carbohydrate Excipients Market Scenario by Region
3.1 Global Pharmaceutical Carbohydrate Excipients Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Carbohydrate Excipients Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Carbohydrate Excipients Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Carbohydrate Excipients Sales by Region: 2026-2031
3.3 Global Pharmaceutical Carbohydrate Excipients Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Carbohydrate Excipients Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Carbohydrate Excipients Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Carbohydrate Excipients Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Carbohydrate Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Carbohydrate Excipients Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Carbohydrate Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Carbohydrate Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Carbohydrate Excipients Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Carbohydrate Excipients Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Carbohydrate Excipients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Carbohydrate Excipients Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Carbohydrate Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pharmaceutical Carbohydrate Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Carbohydrate Excipients Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Carbohydrate Excipients Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Carbohydrate Excipients Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Carbohydrate Excipients Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Carbohydrate Excipients Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Carbohydrate Excipients Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Carbohydrate Excipients Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Carbohydrate Excipients Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Carbohydrate Excipients Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Carbohydrate Excipients Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Carbohydrate Excipients Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Carbohydrate Excipients Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Carbohydrate Excipients Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Carbohydrate Excipients Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Carbohydrate Excipients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfanstiehl
6.1.1 Pfanstiehl Company Information
6.1.2 Pfanstiehl Description and Business Overview
6.1.3 Pfanstiehl Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfanstiehl Pharmaceutical Carbohydrate Excipients Product Portfolio
6.1.5 Pfanstiehl Recent Developments/Updates
6.2 ADM
6.2.1 ADM Company Information
6.2.2 ADM Description and Business Overview
6.2.3 ADM Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ADM Pharmaceutical Carbohydrate Excipients Product Portfolio
6.2.5 ADM Recent Developments/Updates
6.3 Protheragen-ING
6.3.1 Protheragen-ING Company Information
6.3.2 Protheragen-ING Description and Business Overview
6.3.3 Protheragen-ING Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Protheragen-ING Pharmaceutical Carbohydrate Excipients Product Portfolio
6.3.5 Protheragen-ING Recent Developments/Updates
6.4 DFE Pharma
6.4.1 DFE Pharma Company Information
6.4.2 DFE Pharma Description and Business Overview
6.4.3 DFE Pharma Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 DFE Pharma Pharmaceutical Carbohydrate Excipients Product Portfolio
6.4.5 DFE Pharma Recent Developments/Updates
6.5 Meggle-Pharma
6.5.1 Meggle-Pharma Company Information
6.5.2 Meggle-Pharma Description and Business Overview
6.5.3 Meggle-Pharma Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Meggle-Pharma Pharmaceutical Carbohydrate Excipients Product Portfolio
6.5.5 Meggle-Pharma Recent Developments/Updates
6.6 Roquette
6.6.1 Roquette Company Information
6.6.2 Roquette Description and Business Overview
6.6.3 Roquette Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roquette Pharmaceutical Carbohydrate Excipients Product Portfolio
6.6.5 Roquette Recent Developments/Updates
6.7 Kerry Group
6.7.1 Kerry Group Company Information
6.7.2 Kerry Group Description and Business Overview
6.7.3 Kerry Group Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kerry Group Pharmaceutical Carbohydrate Excipients Product Portfolio
6.7.5 Kerry Group Recent Developments/Updates
6.8 Colorcon
6.8.1 Colorcon Company Information
6.8.2 Colorcon Description and Business Overview
6.8.3 Colorcon Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Colorcon Pharmaceutical Carbohydrate Excipients Product Portfolio
6.8.5 Colorcon Recent Developments/Updates
6.9 Signet
6.9.1 Signet Company Information
6.9.2 Signet Description and Business Overview
6.9.3 Signet Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Signet Pharmaceutical Carbohydrate Excipients Product Portfolio
6.9.5 Signet Recent Developments/Updates
6.10 IMCD
6.10.1 IMCD Company Information
6.10.2 IMCD Description and Business Overview
6.10.3 IMCD Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.10.4 IMCD Pharmaceutical Carbohydrate Excipients Product Portfolio
6.10.5 IMCD Recent Developments/Updates
6.11 SPI Pharma
6.11.1 SPI Pharma Company Information
6.11.2 SPI Pharma Description and Business Overview
6.11.3 SPI Pharma Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SPI Pharma Pharmaceutical Carbohydrate Excipients Product Portfolio
6.11.5 SPI Pharma Recent Developments/Updates
6.12 Huakang Pharma
6.12.1 Huakang Pharma Company Information
6.12.2 Huakang Pharma Description and Business Overview
6.12.3 Huakang Pharma Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Huakang Pharma Pharmaceutical Carbohydrate Excipients Product Portfolio
6.12.5 Huakang Pharma Recent Developments/Updates
6.13 Hanjiang Pharma
6.13.1 Hanjiang Pharma Company Information
6.13.2 Hanjiang Pharma Description and Business Overview
6.13.3 Hanjiang Pharma Pharmaceutical Carbohydrate Excipients Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hanjiang Pharma Pharmaceutical Carbohydrate Excipients Product Portfolio
6.13.5 Hanjiang Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Carbohydrate Excipients Industry Chain Analysis
7.2 Pharmaceutical Carbohydrate Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Carbohydrate Excipients Production Mode & Process Analysis
7.4 Pharmaceutical Carbohydrate Excipients Sales and Marketing
7.4.1 Pharmaceutical Carbohydrate Excipients Sales Channels
7.4.2 Pharmaceutical Carbohydrate Excipients Distributors
7.5 Pharmaceutical Carbohydrate Excipients Customer Analysis
8 Pharmaceutical Carbohydrate Excipients Market Dynamics
8.1 Pharmaceutical Carbohydrate Excipients Industry Trends
8.2 Pharmaceutical Carbohydrate Excipients Market Drivers
8.3 Pharmaceutical Carbohydrate Excipients Market Challenges
8.4 Pharmaceutical Carbohydrate Excipients Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Carbohydrate Excipients Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharmaceutical Carbohydrate Excipients Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharmaceutical Carbohydrate Excipients Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharmaceutical Carbohydrate Excipients Sales (Tons) of Key Manufacturers (2020-2025)
Table 5. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Carbohydrate Excipients Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharmaceutical Carbohydrate Excipients Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharmaceutical Carbohydrate Excipients Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharmaceutical Carbohydrate Excipients, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Carbohydrate Excipients, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Carbohydrate Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Carbohydrate Excipients as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Carbohydrate Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharmaceutical Carbohydrate Excipients Sales by Region (2020-2025) & (Tons)
Table 18. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Carbohydrate Excipients Sales by Region (2026-2031) & (Tons)
Table 20. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Region (2026-2031)
Table 21. Global Pharmaceutical Carbohydrate Excipients Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Region (2020-2025)
Table 23. Global Pharmaceutical Carbohydrate Excipients Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Region (2026-2031)
Table 25. North America Pharmaceutical Carbohydrate Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2025) & (Tons)
Table 27. North America Pharmaceutical Carbohydrate Excipients Sales by Country (2026-2031) & (Tons)
Table 28. North America Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharmaceutical Carbohydrate Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharmaceutical Carbohydrate Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2025) & (Tons)
Table 32. Europe Pharmaceutical Carbohydrate Excipients Sales by Country (2026-2031) & (Tons)
Table 33. Europe Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharmaceutical Carbohydrate Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Carbohydrate Excipients Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Carbohydrate Excipients Sales by Region (2020-2025) & (Tons)
Table 37. Asia Pacific Pharmaceutical Carbohydrate Excipients Sales by Region (2026-2031) & (Tons)
Table 38. Asia Pacific Pharmaceutical Carbohydrate Excipients Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Carbohydrate Excipients Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmaceutical Carbohydrate Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2025) & (Tons)
Table 42. Latin America Pharmaceutical Carbohydrate Excipients Sales by Country (2026-2031) & (Tons)
Table 43. Latin America Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Carbohydrate Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharmaceutical Carbohydrate Excipients Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharmaceutical Carbohydrate Excipients Sales by Country (2020-2025) & (Tons)
Table 47. Middle East and Africa Pharmaceutical Carbohydrate Excipients Sales by Country (2026-2031) & (Tons)
Table 48. Middle East and Africa Pharmaceutical Carbohydrate Excipients Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharmaceutical Carbohydrate Excipients Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharmaceutical Carbohydrate Excipients Sales (Tons) by Type (2020-2025)
Table 51. Global Pharmaceutical Carbohydrate Excipients Sales (Tons) by Type (2026-2031)
Table 52. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Type (2020-2025)
Table 53. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Type (2026-2031)
Table 54. Global Pharmaceutical Carbohydrate Excipients Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharmaceutical Carbohydrate Excipients Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Type (2020-2025)
Table 57. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Type (2026-2031)
Table 58. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Type (2020-2025)
Table 59. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Type (2026-2031)
Table 60. Global Pharmaceutical Carbohydrate Excipients Sales (Tons) by Application (2020-2025)
Table 61. Global Pharmaceutical Carbohydrate Excipients Sales (Tons) by Application (2026-2031)
Table 62. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Application (2020-2025)
Table 63. Global Pharmaceutical Carbohydrate Excipients Sales Market Share by Application (2026-2031)
Table 64. Global Pharmaceutical Carbohydrate Excipients Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharmaceutical Carbohydrate Excipients Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Application (2020-2025)
Table 67. Global Pharmaceutical Carbohydrate Excipients Revenue Market Share by Application (2026-2031)
Table 68. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Application (2020-2025)
Table 69. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Application (2026-2031)
Table 70. Pfanstiehl Company Information
Table 71. Pfanstiehl Description and Business Overview
Table 72. Pfanstiehl Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Pfanstiehl Pharmaceutical Carbohydrate Excipients Product
Table 74. Pfanstiehl Recent Developments/Updates
Table 75. ADM Company Information
Table 76. ADM Description and Business Overview
Table 77. ADM Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. ADM Pharmaceutical Carbohydrate Excipients Product
Table 79. ADM Recent Developments/Updates
Table 80. Protheragen-ING Company Information
Table 81. Protheragen-ING Description and Business Overview
Table 82. Protheragen-ING Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Protheragen-ING Pharmaceutical Carbohydrate Excipients Product
Table 84. Protheragen-ING Recent Developments/Updates
Table 85. DFE Pharma Company Information
Table 86. DFE Pharma Description and Business Overview
Table 87. DFE Pharma Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. DFE Pharma Pharmaceutical Carbohydrate Excipients Product
Table 89. DFE Pharma Recent Developments/Updates
Table 90. Meggle-Pharma Company Information
Table 91. Meggle-Pharma Description and Business Overview
Table 92. Meggle-Pharma Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Meggle-Pharma Pharmaceutical Carbohydrate Excipients Product
Table 94. Meggle-Pharma Recent Developments/Updates
Table 95. Roquette Company Information
Table 96. Roquette Description and Business Overview
Table 97. Roquette Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Roquette Pharmaceutical Carbohydrate Excipients Product
Table 99. Roquette Recent Developments/Updates
Table 100. Kerry Group Company Information
Table 101. Kerry Group Description and Business Overview
Table 102. Kerry Group Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Kerry Group Pharmaceutical Carbohydrate Excipients Product
Table 104. Kerry Group Recent Developments/Updates
Table 105. Colorcon Company Information
Table 106. Colorcon Description and Business Overview
Table 107. Colorcon Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Colorcon Pharmaceutical Carbohydrate Excipients Product
Table 109. Colorcon Recent Developments/Updates
Table 110. Signet Company Information
Table 111. Signet Description and Business Overview
Table 112. Signet Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Signet Pharmaceutical Carbohydrate Excipients Product
Table 114. Signet Recent Developments/Updates
Table 115. IMCD Company Information
Table 116. IMCD Description and Business Overview
Table 117. IMCD Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. IMCD Pharmaceutical Carbohydrate Excipients Product
Table 119. IMCD Recent Developments/Updates
Table 120. SPI Pharma Company Information
Table 121. SPI Pharma Description and Business Overview
Table 122. SPI Pharma Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. SPI Pharma Pharmaceutical Carbohydrate Excipients Product
Table 124. SPI Pharma Recent Developments/Updates
Table 125. Huakang Pharma Company Information
Table 126. Huakang Pharma Description and Business Overview
Table 127. Huakang Pharma Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Huakang Pharma Pharmaceutical Carbohydrate Excipients Product
Table 129. Huakang Pharma Recent Developments/Updates
Table 130. Hanjiang Pharma Company Information
Table 131. Hanjiang Pharma Description and Business Overview
Table 132. Hanjiang Pharma Pharmaceutical Carbohydrate Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Hanjiang Pharma Pharmaceutical Carbohydrate Excipients Product
Table 134. Hanjiang Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Pharmaceutical Carbohydrate Excipients Distributors List
Table 138. Pharmaceutical Carbohydrate Excipients Customers List
Table 139. Pharmaceutical Carbohydrate Excipients Market Trends
Table 140. Pharmaceutical Carbohydrate Excipients Market Drivers
Table 141. Pharmaceutical Carbohydrate Excipients Market Challenges
Table 142. Pharmaceutical Carbohydrate Excipients Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Carbohydrate Excipients
Figure 2. Global Pharmaceutical Carbohydrate Excipients Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Carbohydrate Excipients Market Share by Type: 2024 & 2031
Figure 4. Sucrose Product Picture
Figure 5. Glucose Product Picture
Figure 6. Starch Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pharmaceutical Carbohydrate Excipients Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharmaceutical Carbohydrate Excipients Market Share by Application: 2024 & 2031
Figure 10. Oral Preparations
Figure 11. Injectable Preparations
Figure 12. Topical Preparations
Figure 13. Others
Figure 14. Global Pharmaceutical Carbohydrate Excipients Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Carbohydrate Excipients Market Size (2020-2031) & (US$ Million)
Figure 16. Global Pharmaceutical Carbohydrate Excipients Sales (2020-2031) & (Tons)
Figure 17. Global Pharmaceutical Carbohydrate Excipients Average Price (US$/Ton) & (2020-2031)
Figure 18. Pharmaceutical Carbohydrate Excipients Report Years Considered
Figure 19. Pharmaceutical Carbohydrate Excipients Sales Share by Manufacturers in 2024
Figure 20. Global Pharmaceutical Carbohydrate Excipients Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Pharmaceutical Carbohydrate Excipients Players: Market Share by Revenue in Pharmaceutical Carbohydrate Excipients in 2024
Figure 22. Pharmaceutical Carbohydrate Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Pharmaceutical Carbohydrate Excipients Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Pharmaceutical Carbohydrate Excipients Sales Market Share by Country (2020-2031)
Figure 25. North America Pharmaceutical Carbohydrate Excipients Revenue Market Share by Country (2020-2031)
Figure 26. United States Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Pharmaceutical Carbohydrate Excipients Sales Market Share by Country (2020-2031)
Figure 29. Europe Pharmaceutical Carbohydrate Excipients Revenue Market Share by Country (2020-2031)
Figure 30. Germany Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Pharmaceutical Carbohydrate Excipients Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Pharmaceutical Carbohydrate Excipients Revenue Market Share by Region (2020-2031)
Figure 37. China Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Pharmaceutical Carbohydrate Excipients Sales Market Share by Country (2020-2031)
Figure 45. Latin America Pharmaceutical Carbohydrate Excipients Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Colombia Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Pharmaceutical Carbohydrate Excipients Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Pharmaceutical Carbohydrate Excipients Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Pharmaceutical Carbohydrate Excipients Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Pharmaceutical Carbohydrate Excipients by Type (2020-2031)
Figure 56. Global Revenue Market Share of Pharmaceutical Carbohydrate Excipients by Type (2020-2031)
Figure 57. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Type (2020-2031)
Figure 58. Global Sales Market Share of Pharmaceutical Carbohydrate Excipients by Application (2020-2031)
Figure 59. Global Revenue Market Share of Pharmaceutical Carbohydrate Excipients by Application (2020-2031)
Figure 60. Global Pharmaceutical Carbohydrate Excipients Price (US$/Ton) by Application (2020-2031)
Figure 61. Pharmaceutical Carbohydrate Excipients Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
